California State Teachers Retirement System (CalSTRS)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.3M Buy
1,277,169
+32,425
+3% +$1.08M 0.04% 330
2026
Q1
$37.5M Buy
1,244,744
+18,779
+2% +$604K 0.04% 343
2025
Q4
$38.3M Buy
1,225,965
+10,901
+0.9% +$269K 0.04% 354
2025
Q3
$24.5M Sell
1,215,064
-11,173
-0.9% -$196K 0.03% 464
2025
Q2
$20.6M Buy
1,226,237
+14,387
+1% +$232K 0.02% 496
2025
Q1
$18.6M Sell
1,211,850
-29,412
-2% -$525K 0.02% 509
2024
Q4
$27.4M Sell
1,241,262
-110,266
-8% -$2.01M 0.03% 427
2024
Q3
$24.4M Sell
1,351,528
-24,272
-2% -$425K 0.03% 471
2024
Q2
$22.4M Buy
1,375,800
+1,569
+0.1% +$24.2K 0.03% 469
2024
Q1
$19.4M Buy
1,374,231
+167,786
+14% +$2.11M 0.02% 506
2023
Q4
$12.6M Sell
1,206,445
-7,601
-0.6% -$71K 0.02% 586
2023
Q3
$12.4M Buy
1,214,046
+44,568
+4% +$415K 0.02% 578
2023
Q2
$8.81M Sell
1,169,478
-1,913
-0.2% -$15.5K 0.01% 696
2023
Q1
$10.4M Sell
1,171,391
-6,858
-0.6% -$67.8K 0.02% 635
2022
Q4
$10.7M Sell
1,178,249
-24,133
-2% -$211K 0.02% 628
2022
Q3
$9.7M Sell
1,202,382
-45,394
-4% -$401K 0.02% 640
2022
Q2
$9.38M Buy
1,247,776
+22,201
+2% +$193K 0.01% 657
2022
Q1
$11.5M Buy
1,225,575
+14,277
+1% +$119K 0.02% 659
2021
Q4
$9.7M Buy
1,211,298
+131,816
+12% +$1.19M 0.01% 791
2021
Q3
$10.5M Sell
1,079,482
-74,011
-6% -$693K 0.01% 788
2021
Q2
$11.4M Sell
1,153,493
-55,788
-5% -$590K 0.01% 769
2021
Q1
$14M Sell
1,209,281
-87,937
-7% -$1.01M 0.02% 674
2020
Q4
$12.5M Buy
1,297,218
+814
+0.1% +$7.8K 0.02% 674
2020
Q3
$11.7M Buy
1,296,404
+9,783
+0.8% +$103K 0.02% 635
2020
Q2
$15.9M Buy
1,286,621
+80,786
+7% +$914K 0.03% 496
2020
Q1
$10.8M Buy
1,205,835
+6,249
+0.5% +$64K 0.02% 538
2019
Q4
$11.8M Buy
1,199,586
+28,085
+2% +$251K 0.02% 630
2019
Q3
$8.06M Buy
1,171,501
+13,446
+1% +$103K 0.02% 736
2019
Q2
$10.7M Buy
1,158,055
+420,903
+57% +$5.08M 0.02% 644
2019
Q1
$11.6M Buy
737,152
+4,472
+0.6% +$78.9K 0.02% 586
2018
Q4
$11.3M Buy
732,680
+69,457
+10% +$1.42M 0.03% 545
2018
Q3
$14.3M Buy
663,223
+4,019
+0.6% +$93.3K 0.03% 534
2018
Q2
$16M Buy
659,204
+43,291
+7% +$883K 0.03% 488
2018
Q1
$10.5M Buy
615,913
+2,289
+0.4% +$44.7K 0.02% 620
2017
Q4
$11.6M Buy
613,624
+232
+0% +$3.49K 0.02% 609
2017
Q3
$10.8M Buy
613,392
+5,860
+1% +$132K 0.02% 605
2017
Q2
$20.2M Buy
607,532
+5,366
+0.9% +$166K 0.04% 397
2017
Q1
$19.3M Buy
602,166
+28,071
+5% +$958K 0.04% 433
2016
Q4
$20.8M Buy
+574,095
New +$22.9M 0.04% 408

Other funds holding TEVA

California State Teachers Retirement System (CalSTRS)'s TEVA Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Teva Pharmaceuticals (TEVA) stake by 2.6% in Q2 2026, buying an estimated $1.08M and bringing the position to 1,277,169 shares worth $43.3M. The position accounts for 0.04% of the portfolio, ranked #330.

California State Teachers Retirement System (CalSTRS) first reported a position in TEVA in Q4 2016 and has held it in 39 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 1,277,169 shares of Teva Pharmaceuticals worth $43.3M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 32,425 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.08M.
  • Teva Pharmaceuticals made up 0.04% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #330 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.